Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70

References

• Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802:396–405.
   PubMed Web of Science ®Google Scholar
• Wang X, Gocek E, Novik V, et al. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D(3). Cell Cycle. 2010;9:4542–4551.
   PubMed Web of Science ®Google Scholar
• Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75:50–83.
   PubMed Web of Science ®Google Scholar
• Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol. 1999;11:211–218.
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537–549.
   PubMed Web of Science ®Google Scholar
• Zanke BW, Rubie EA, Winnett E, et al. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes. J Biol Chem. 1996;271:29876–29881.
   PubMed Web of Science ®Google Scholar
• Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22.
   PubMed Web of Science ®Google Scholar
• Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291–3310.
   PubMed Web of Science ®Google Scholar
• Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279–3290.
   PubMed Web of Science ®Google Scholar
• Lovicu FJ, McAvoy JW. FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signaling. Development. 2001;128:5075–5084.
   PubMed Web of Science ®Google Scholar
• Miranda MB, McGuire TF, Johnson DE. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia. 2002;16:683–692.
   PubMed Web of Science ®Google Scholar
• Ge C, Xiao G, Jiang D, et al. Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol. 2007;176:709–718.
   PubMed Web of Science ®Google Scholar
• Ji Y, Kutner A, Verstuyf A, et al. Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle. 2002;1:410–415.
   PubMed Web of Science ®Google Scholar
• Gocek E, Studzinski GP. Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci. 2009;46:190–209.
   PubMed Web of Science ®Google Scholar
• Kato Y, Kravchenko VV, Tapping RI, et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 1997;16:7054–7066.
   PubMed Web of Science ®Google Scholar
• Wang X, Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 2006;18:753–760.
   PubMed Web of Science ®Google Scholar
• Drew BA, Burow ME, Beckman BS. MEK5/ERK5 pathway: the first fifteen years. Biochim Biophys Acta. 2012;1825:37–48.
   PubMed Web of Science ®Google Scholar
• Esparís-Ogando A, Díaz-Rodríguez E, Montero JC, et al. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol. 2002;22:270–285.
   PubMed Web of Science ®Google Scholar
• Mehta PB, Jenkins BL, McCarthy L, et al. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene. 2003;22:1381–1389.
   PubMed Web of Science ®Google Scholar
• Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006;7:782–786.
   PubMed Web of Science ®Google Scholar
• Ostrander JH, Daniel AR, Lofgren K, et al. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 2007;67:4199–4209.
   Google Scholar
• McCracken SR, Ramsay A, Heer R, et al. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer. Oncogene. 2008;27:2978–2988.
   PubMed Web of Science ®Google Scholar
• Zhou C, Nitschke AM, Xiong W, et al. Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008;10:R105.
   Google Scholar
• Nithianandarajah-Jones GN, Wilm B, Goldring CE, et al. ERK5: structure, regulation and function. Cell Signal. 2012;24:2187–2196.
   PubMed Web of Science ®Google Scholar
• Kasler HG, Victoria J, Duramad O, et al. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol Cell Biol. 2000;20:8382–8389.
   PubMed Web of Science ®Google Scholar
• Kondoh K, Terasawa K, Morimoto H, et al. Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms. Mol Cell Biol. 2006;26:1679–1690.
   PubMed Web of Science ®Google Scholar
• Erazo T, Moreno A, Ruiz-Babot G, et al. Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex. Mol Cell Biol. 2013;33:1671–1686.
   PubMed Web of Science ®Google Scholar
• Buschbeck M, Ullrich A. The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J Biol Chem. 2005;280:2659–2667.
   PubMed Web of Science ®Google Scholar
• Tatake RJ, O'Neill MM, Kennedy CA, et al. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway. Biochem Biophys Res Commun. 2008;377:120–125.
   PubMed Web of Science ®Google Scholar
• Wang X, Pesakhov S, Weng A, et al. ERK 5/MAPK pathway has a major role in 1α,25-(OH)2 vitamin D3-induced terminal differentiation of myeloid leukemia cells. J Steroid Biochem Mol Biol. 2013;144:223–227.
   PubMed Web of Science ®Google Scholar
• Wang X, Pesakhov S, Harrison JS, et al. The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage. Exp Cell Res. 2015;330:199–211.
   PubMed Web of Science ®Google Scholar
• Nakajima H. Role of transcription factors in differentiation and reprogramming of hematopoietic cells. Keio J Med. 2011;60:47–55.
   PubMedGoogle Scholar
• Feng R, Desbordes SC, Xie H, et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA. 2008;105:6057–6062.
   PubMed Web of Science ®Google Scholar
• Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117:663–676.
   PubMed Web of Science ®Google Scholar
• Pahl HL, Scheibe RJ, Zhang DE, et al. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem. 1993;268:5014–5020.
   PubMed Web of Science ®Google Scholar
• Cai DH, Wang D, Keefer J, et al. C/EBP alpha: AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1. Oncogene. 2008;27:2772–2779.
   PubMed Web of Science ®Google Scholar
• Gupta P, Gurudutta GU, Saluja D, et al. PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis. J Cell Mol Med. 2009;13:4349–4363.
   PubMed Web of Science ®Google Scholar
• Arndt V, Rogon C, Höhfeld J. To be, or not to be-molecular chaperones in protein degradation. Cell Mol Life Sci. 2007;64:2525–2541.
   PubMed Web of Science ®Google Scholar
• Zuehlke A, Johnson JL. Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers. 2010;93:211–217.
   PubMed Web of Science ®Google Scholar
• Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet. 1998;22:631–677.
   Web of Science ®Google Scholar
• Zheng R, Heck DE, Black AT, et al. Regulation of keratinocyte expression of stress proteins and antioxidants by the electrophilic nitrofatty acids 9- and 10-nitrooleic acid. Free Radic Biol Med. 2014;67:1–9.
   PubMed Web of Science ®Google Scholar
• Gething MJ, Sambrook J. Protein folding in the cell. Nature. 1992;355:33–45.
   PubMed Web of Science ®Google Scholar
• Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol. 1995;11:441–469.
   PubMed Web of Science ®Google Scholar
• Brown CR, Martin RL, Hansen WJ, et al. The constitutive and stress inducible forms of hsp70 exhibit functional similarities and interact with one another in an ATP-dependent fashion. J Cell Biol. 1993;120:1101–1112.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia. 2002;16:455–462.
   PubMed Web of Science ®Google Scholar
• Arispe N, Doh M, Simakova O, et al. Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J. 2004;18:1636–1645.
   PubMed Web of Science ®Google Scholar
• Truman AW, Millson SH, Nuttall JM, et al. Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase. Eukaryote Cell. 2006;5:1914–1924.
   PubMed Web of Science ®Google Scholar
• Marcinkowska E, Gocek E. Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells. J Steroid Biochem Mol Biol. 2010;121:114–116.
   PubMed Web of Science ®Google Scholar
• Taipale M, Krykbaeva I, Koeva M, et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012;150:987–1001.
   PubMed Web of Science ®Google Scholar
• Jego G, Lanneau D, De Thonel A, et al. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes. Leukemia. 2014;28:1676–1686.
   PubMed Web of Science ®Google Scholar
• Szabo A, Langer T, Schröder H, et al. The ATP hydrolysis-dependent reaction cycle of the Escherichia coli Hsp70 system DnaK, DnaJ, and GrpE. Proc Natl Acad Sci USA. 1994;91:10345–10349.
   PubMed Web of Science ®Google Scholar
• Freeman BC, Myers MP, Schumacher R, et al. Identification of a regulatory motif in Hsp70 that affects ATPase activity, substrate binding and interaction with HDJ-1. EMBO J. 1995;14:2281–2292.
   PubMed Web of Science ®Google Scholar
• Panaretou B, Prodromou C, Roe SM, et al. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 1998;17:4829–4836.
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49–61.
   PubMed Web of Science ®Google Scholar
• Wang T, Xiao M, Ge Y, et al. BRAF inhibition stimulates melanoma-associated macrophages to drive tumor growth. Clin Cancer Res. 2015;21:1652–1664.
   PubMed Web of Science ®Google Scholar
• Sica A, Saccani A, Mantovani A. Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol. 2002;2:1045–1054.
   PubMed Web of Science ®Google Scholar
• Medrek C, Pontén F, Jirström K, et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306.
   PubMed Web of Science ®Google Scholar
• Zheng R, Wang X, Studzinski GP. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C. J Steroid Biochem Mol Biol. 2015;148:132–137.
   PubMed Web of Science ®Google Scholar
• Macias AT, Williamson DS, Allen N, et al. Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity. J Med Chem. 2011;54:4034–4041.
   PubMed Web of Science ®Google Scholar
• Schlecht R, Scholz SR, Dahmen H, et al. Functional analysis of Hsp70 inhibitors. PLoS One. 2013;8:e78443.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Somoza C, Shigematsu H, et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood. 2005;106:1590–1600.
   PubMed Web of Science ®Google Scholar
• Kueh HY1, Champhekar A, Nutt SL, et al. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science. 2013;341:670–673.
   PubMed Web of Science ®Google Scholar
• Lanneau D, Thonel A, Maurel S, et al. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion. 2007;1:53–60.
   PubMed Web of Science ®Google Scholar